Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at HUF 29.05T, ahead of Johnson & Johnson (HUF 27.4T) and Sanofi (HUF 26.61T). Figures as of 18 Nov 2026, 21:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerHUF 29.05T
- Median
- HUF 295B
- Combined market value
- HUF 1699.58T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | HUF 29.05T | HUF 53.73T | HUF 9,427.35 | 1.44% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | HUF 27.4T | HUF 220.57T | HUF 91,625.74 | 2.15% down | 38% up | ||
| 3 | SanofiSNY · Health Care | HUF 26.61T | HUF 38.01T | HUF 15,830.91 | 0.86% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | HUF 17.67T | HUF 114.09T | HUF 46,279.87 | 3.92% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | HUF 17.51T | HUF 60.8T | HUF 35,105.51 | 0.21% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | HUF 16.35T | HUF 93.15T | HUF 60,061.36 | 1.92% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | HUF 15.63T | HUF 22.84T | HUF 7,147.76 | 1.69% down | 54% up | ||
| 8 | NovartisNVS · Health Care | HUF 15.5T | HUF 98.52T | HUF 52,162.70 | 2.43% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | HUF 10.5T | HUF 32.86T | HUF 317,669.71 | 1.28% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | HUF 9.67T | HUF 58.42T | HUF 13,254.02 | 3.07% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | HUF 8.91T | HUF 413.68T | HUF 464,416.37 | 2.35% down | 35% up | ||
| 12 | GSKGSK · Health Care | HUF 7.3T | HUF 32.72T | HUF 16,321.42 | 1.34% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | HUF 6.27T | HUF 45.7T | HUF 180,231.11 | 0.42% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | HUF 6.21T | HUF 40.9T | HUF 20,010.37 | 2.92% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | HUF 4.94T | HUF 7.81T | HUF 6,813.47 | 0.83% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | HUF 3.26T | HUF 13.27T | HUF 23,071.06 | 0.01% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 2.66T | HUF 16.54T | HUF 14,179.28 | 0.98% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | HUF 2.38T | HUF 8.26T | HUF 193,968.92 | 1.16% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | HUF 2.2T | HUF 4.48T | HUF 8,967.04 | 3.25% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | HUF 2.05T | HUF 4T | HUF 20,638.64 | 4.99% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | HUF 1.96T | HUF 1.94T | HUF 2,845.67 | 1.85% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | HUF 1.96T | HUF 10.56T | HUF 17,124.39 | 1.91% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | HUF 1.52T | HUF 9.43T | HUF 13,012.12 | 0.05% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | HUF 1.47T | HUF 15.49T | HUF 135,597.49 | 2.34% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 1.45T | HUF 5.34T | HUF 83,243.29 | 2.93% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 1.35T | HUF 4.2T | HUF 5,032.83 | 1.28% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | HUF 1.12T | HUF 11.68T | HUF 28,749.29 | 2.50% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | HUF 611.2B | HUF 2.65T | HUF 15,740.19 | 3.08% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | HUF 341.8B | HUF 2.01T | HUF 100,357.60 | 1.67% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | HUF 336.7B | HUF 1.06T | HUF 5,459.51 | 0.87% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | HUF 295B | HUF 2.87T | HUF 102,534.68 | 0.04% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | HUF 265.1B | HUF 6.72T | HUF 50,193.92 | 4.54% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | HUF 258.9B | HUF 2.13T | HUF 52,488.59 | 0.94% down | 31% up | ||
| 34 | InsmedINSM · Health Care | HUF 248.3B | HUF 8.83T | HUF 40,249.21 | 1.69% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | HUF 240.3B | HUF 3.24T | HUF 34,087.52 | 8.15% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | HUF 221.4B | HUF 2.82T | HUF 3,527.69 | 1.59% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | HUF 217.7B | HUF 3.36T | HUF 22,214.34 | 5.44% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | HUF 217.6B | HUF 2.49T | HUF 22,775.41 | 3.25% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | HUF 213.8B | HUF 1.63T | HUF 9,343.33 | 0.14% down | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | HUF 206.5B | HUF 2.79T | HUF 42,721.95 | 2.00% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 202.5B | HUF 3.11T | HUF 133,742.94 | 5.67% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 190.7B | HUF 2.51T | HUF 31,933.95 | 0.06% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | HUF 175.5B | HUF 1.52T | HUF 13,899.08 | 1.59% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | HUF 169.7B | HUF 2.47T | HUF 28,164.37 | 2.11% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | HUF 165.8B | HUF 1.59T | HUF 28,214.76 | 3.45% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | HUF 164.3B | HUF 1.53T | HUF 9,202.22 | 1.59% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | HUF 158.6B | HUF 2.18T | HUF 32,165.77 | 0.60% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 156.6B | HUF 2.05T | HUF 14,483.67 | 0.28% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | HUF 111.7B | HUF 1.34T | HUF 9,783.45 | 0.88% down | 169% up | ||
| 50 | ErascaERAS · Health Care | HUF 109.2B | HUF 1.62T | HUF 4,622.95 | 0.94% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | HUF 105.7B | HUF 2.03T | HUF 31,073.87 | 0.59% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 46.7B | HUF 2.77T | HUF 39,993.87 | 2.08% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | HUF 38.6B | HUF 1.62T | HUF 16,879.13 | 1.68% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | HUF 29.7B | HUF 2.37T | HUF 45,019.98 | 1.43% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -HUF 23.8B | HUF 2.56T | HUF 7,351.02 | 3.60% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -HUF 40.7B | HUF 1.77T | HUF 41,960.97 | 0.59% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -HUF 60.7B | HUF 5.96T | HUF 90,822.77 | 0.32% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -HUF 69B | HUF 1.69T | HUF 20,235.47 | 0.22% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -HUF 221.6B | HUF 2.4T | HUF 17,241.98 | 0.64% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -HUF 701B | HUF 5.11T | HUF 26,209.02 | 1.58% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -HUF 1.1T | HUF 169.82T | HUF 96,073.98 | 2.34% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 336.0 HUF).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (HUF 29.05T), Johnson & Johnson (HUF 27.4T) and Sanofi (HUF 26.61T) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 21:08 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of HUF 1699.58T as of 18 Nov 2026, 21:08 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.